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Accidental ingestional poisoning among pediatric patients 
is a prevalent problem. In the absence of a well-designed 
national injury and poisoning surveillance system, cases often 
go unreported. Underreporting also occurs because many 
pediatric ingestions are trivial and not referred to a hospital for 
further medical management.1 To reduce health risks posed by 
common household products, emphasis and enforcement of 
regulations specifying child-safe packaging are required.2
The authors described two cases of methemoglobinemia 
(metHbemia) and sulfhemoglobinemia (sulfHbemia) 
following ingestion of hydroxylamine sulfate, which were 
treated with methylene blue and exchange transfusion. 
Drugs or chemicals that cause sulfHbemia can also cause 
metHbemia, although it is not understood why the same 
chemical causes metHbemia in one person and sulfHbemia 
in another.3 Other ingestants that may cause methHbemia and 
sulfHbemia are dapsone, metoclopramide, phenacetin and 
phenazopyridine.
Emergency physicians (EP) in some developing countries 
may not have access to lab equipment with advanced 
co-oximeter capabilities to differentiate the two types of 
dyshemoglobinemia. In a time-pressured situation, some 
bedside investigation methods may be useful in guiding 
decisions for specific therapy like methylene blue in a 
cyanosed patient with suspected poisoning. One method, the 
filter paper test, helps to distinguish deoxyhemoglobin from 
dyshemoglobin as the darkly colored blood changes to bright 
red after blowing some oxygen over it. No changes occur 
with metHb or sulfHb. To distinguish metHb from sulfHb, 
the addition of a few drops of potassium cyanide changes 
the chocolate brown of metHb to bright red as cyanometHb 
is formed. No reaction occurs with sulfHb.4 Therapeutic 
response to methylene blue will also aid in the diagnosis of 
underlying metHbemia. The response is usually fairly rapid, 
within 30 minutes to one hour.
EPs should consider several differentials for apparent 
metHbemia that does not respond to methylene blue treatment. 
These include older equipment incapable of distinguishing 
sulfHb from metHb due to limited co-oximeter capability; Hb 
M disease prone to metHb formation that resists reduction; 
glucose-6-phosphate dehydrogenase (G6PD) deficiency; 
NADPH metHb reductase deficiency; poisoning with 
oxidizing compounds that have enterohepatic circulation, 
which causes prolonged elevation of metHb; and overdosing 
of methylene blue itself, which is an oxidizing agent.3,4
Finally, G6PD deficiency, one of the most prevalent 
disease-causing mutations worldwide, has several variants 
in Asia. Patient’s status will influence decision when 
using methylene blue as treatment for metHbemia because 
methylene blue itself may induce hemolysis (through 
development of Heinz bodies) and cause paradoxical 
metHbemia, especially in G6PD deficient patients.4
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